MedTrace Logo

Sorafenib-induced Hand- Foot Skin Reaction Treatment

NCT00667589 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2013-06-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate treatments for a rash caused by sorafenib.

Conditions

  • Hand-foot Skin Reaction
  • Rash

Interventions

DRUG

urea 40% cream

urea 40% cream applied twice per day to affected areas

DRUG

fluocinonide 0.05% cream

fluocinonide 0.05% cream applied twice per day to affected areas

DRUG

tazarotene 0.1% cream

tazarotene 0.1% cream applied twice per day to affected areas

DRUG

bland emollient cream (Udderly smooth® Udder Cream)

bland emollient cream applied twice per day to affected areas

Sponsors & Collaborators

Principal Investigators

  • Dennis West, PhD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00667589 on ClinicalTrials.gov